SCHEMBL7969128

SCHEMBL7969128

COc1cc(-c2nc(-c3ccccc3)c(N3CCCC3=O)o2)ccc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 1/20 0.48
POLB P06746 2/20 0.42
IDO1 P14902 1/20 0.42
PTGES O14684 2/20 0.41
ALOX5 P09917 1/20 0.41
CHEK1 O14757 1/20 0.41
FGFR1 P11362 1/20 0.41
CDK4 P11802 1/20 0.41
CCNA2 P20248 1/20 0.41
CCND1 P24385 1/20 0.41
CDK2 P24941 1/20 0.41
CCND3 P30281 1/20 0.41
KDR P35968 1/20 0.41
SMPD3 Q9NY59 1/20 0.41
PIK3CG P48736 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP1B1 Q16678 1/20 0.40
NPC1 O15118 2/20 0.40
KDM4E B2RXH2 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746666 0.83 KDM4E (0.41) POLBKDRNPC1KDM4EALDH1A1
SCHEMBL7744215 0.71 KDM4E (0.39) FGFR1KDRNPC1KDM4EHPGD
SCHEMBL7982491 0.70 KDM4E (0.38) POLBKDRNPC1KDM4EHPGD
SCHEMBL7744109 0.70 KDR (0.54) KDRCYP3A4CYP2C9CYP2C19
SCHEMBL11117825 0.70 NPC1 (0.59) POLBCHEK1FGFR1CYP1A2NPC1
SCHEMBL15620225 0.68 MAPT (0.47) POLBCDK2KDM4EHPGDALDH1A1
SCHEMBL15620466 0.66 KDM4E (0.47) POLBCDK2NPC1KDM4EHPGD
SCHEMBL15621527 0.65 MAPT (0.46) POLBCDK2KDM4EHPGDALDH1A1
SCHEMBL1347677 0.65 NPC1 (0.77) POLBALOX5NPC1KDM4EHPGD
SCHEMBL2524920 0.64 POLB (0.62) NOX1POLBIDO1ALOX5CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed